ENTITY CLASS
Thymosin-related peptides
Thymosin alpha-1, thymosin beta-4, and TB-500 records where identity is central to evidence transfer.
CONNECTED RECORDS
Thymosin-related peptides: evidence by entity.
Synthetic peptideHuman evidence 3/5
Thymosin Alpha-1
Thymosin alpha-1 has more human research than many wellness-market peptides, yet the evidence remains indication-specific and does not amount to U.S. approval or a general immune-boosting claim.
Open evidence recordNative peptideHuman evidence 2/5
Thymosin Beta-4
Thymosin beta-4 has early human development work and extensive preclinical biology, but that record does not establish routine systemic recovery use or equivalence to TB-500 products.
Open evidence recordPeptide fragmentHuman evidence 1/5
TB-500
The first question for TB-500 is entity identity: evidence about full-length thymosin beta-4 should not be treated as direct evidence for every TB-500 product.
Open evidence record